Evolent Health director David Farner resigns; Richard Jelinek nominated for board election

Evolent Health, Inc.

David Farner resigns from board effective 2023 annual meeting (June 8, 2023), triggered by UPMC ownership falling below 40%.
Board nominates Richard Jelinek (former Aetna exec, managing partner at Czech One Capital Partners) for election.
Previously announced director Frank Williams also departing in June 2023.
Jelinek brings experience from Aetna, CVS Health, and OptumHealth to value-based specialty care focus.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Farner

Director

EVH · Evolent Health, Inc.

Effective: 2023-06-08
Filed: April 19, 2023, 7:59 PM ET

Mr. David Farner, one of UPMC’s two director nominees, offered to tender his resignation from the Company’s Board of Directors (the “Board”). The Board accepted the resignation on April 19, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Farner resigned as Director at Evolent Health, Inc..

Action: resigned
Role: Director

Exact text from the filing

Mr. David Farner, one of UPMC’s two director nominees, offered to tender his resignation from the Company’s Board of Directors (the “Board”). The Board accepted the resignation on April 19, 2023.

View on SEC.gov

Evolent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628908-23-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.